Business Description

BB Biotech AG
NAICS : 325414
ISIN : CH0038389992
Description
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | 6.2 | |||||
3-Year Book Growth Rate | -4 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 25.96 | |||||
9-Day RSI | 26.33 | |||||
14-Day RSI | 27.12 | |||||
6-1 Month Momentum % | -23.48 | |||||
12-1 Month Momentum % | -20.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 6.8 | |||||
3-Year Dividend Growth Rate | 11.8 | |||||
Forward Dividend Yield % | 6.8 | |||||
5-Year Yield-on-Cost % | 6.84 | |||||
3-Year Average Share Buyback Ratio | 0.3 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 101.87 | |||||
ROE % | -12.34 | |||||
ROA % | -10.99 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 9.33 | |||||
PB Ratio | 0.87 | |||||
Price-to-Tangible-Book | 0.87 | |||||
Price-to-Free-Cash-Flow | 10.13 | |||||
Price-to-Operating-Cash-Flow | 10.13 | |||||
EV-to-Revenue | -7.68 | |||||
EV-to-FCF | 11.73 | |||||
Price-to-Projected-FCF | 0.67 | |||||
Forward Rate of Return (Yacktman) % | 7.14 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
BB Biotech AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | -351.227 | ||
EPS (TTM) (CHF) | -6.5 | ||
Beta | -0.09 | ||
Volatility % | 20.6 | ||
14-Day RSI | 27.12 | ||
14-Day ATR (CHF) | 0.941147 | ||
20-Day SMA (CHF) | 44.3 | ||
12-1 Month Momentum % | -20.4 | ||
52-Week Range (CHF) | 41.45 - 63.8 | ||
Shares Outstanding (Mil) | 54.85 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BB Biotech AG Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |
BB Biotech AG Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
BB Biotech AG Frequently Asked Questions
What is BB Biotech AG(XSWX:BION)'s stock price today?
The current price of XSWX:BION is CHF41.90. The 52 week high of XSWX:BION is CHF63.80 and 52 week low is CHF41.45.
When is next earnings date of BB Biotech AG(XSWX:BION)?
The next earnings date of BB Biotech AG(XSWX:BION) is 2023-07-21.
Does BB Biotech AG(XSWX:BION) pay dividends? If so, how much?
The Dividend Yield %  of BB Biotech AG(XSWX:BION) is 6.8% (As of Today), Highest Dividend Payout Ratio of BB Biotech AG(XSWX:BION) was 0.27. The lowest was 0. And the median was 0.26. The  Forward Dividend Yield % of BB Biotech AG(XSWX:BION) is 6.8%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |